MedPath

A Comparison Between Child-Pugh and Albumin-Bilirubin Scores

Completed
Conditions
Rupture, Spontaneous
Hepatocellular Carcinoma
Rupture Liver
Hepatic Impairment
Registration Number
NCT03534843
Lead Sponsor
Huazhong University of Science and Technology
Brief Summary

To compare Child-Pugh and Albumin-Bilirubin scores in patients with spontaneous rupture of hepatocellular carcinoma

Detailed Description

To compare Child-Pugh and Albumin-Bilirubin scores in patients with spontaneous rupture of hepatocellular carcinoma. And to determine which is better in predicting long-term survival and short-term survival.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
230
Inclusion Criteria
  • Be diagnosed as hepatocellular carcinoma pathologically; had a tumor rupture confirmed by Intraperitoneal exploration or clinical signs and symptoms in combination with imaging examination.
Exclusion Criteria
  • Be diagnosed as not hepatocellular carcinoma pathologically;had repeated transcatheter arterial chemoembolization(TACE) or a long history (more than 1 year) of cancer treatment; loss of follow up or without complete data.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival of all patients5 years

Overall survival of all patients among different Child-Pugh and albumin-bilirubin scores

Secondary Outcome Measures
NameTimeMethod
Short-term mortality of non-surgical subgroupNinety days

Ninety-day mortality of the non-surgical subgroup among different Child-Pugh and albumin-bilirubin scores

Short-term mortality of all patientsNinety days

Ninety-day mortality of all patients among different Child-Pugh and albumin-bilirubin scores

Short-term mortality of surgical subgroupNinety days

Ninety-day mortality of the surgical subgroup among different Child-Pugh and albumin-bilirubin scores

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.